By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

tesa Labtec GmbH 

Raiffeisenstr. 4

Langenfeld    40764  Germany
Phone: 49-2173-9735-0 Fax: 49-2173-9735-35


SEARCH JOBS


Industry
Pharmaceutical






Company News
New Name for Labtec GmbH 2/1/2013 9:10:41 AM
APR Applied Pharma Research S.A. and Labtec GmbH Announce the European Approval of Zolmitriptan Oral Dispersible Film (ODF) 3/1/2012 8:11:27 AM
APR Applied Pharma Research S.A., Labtec GmbH and Norgine Announce the Signature of an Exclusive Licensing Agreement Under Which Norgine will Market and Distribute Setofilm™ 1/18/2012 6:18:01 AM
APR Applied Pharma Research S.A. and Labtec GmbH Announce Ondansetron Oral Dispersible Film (“ODF”) is Now Available for Licensing in Europe and Selected Non European ountries, after Having Received Marketing Authorization in Most Countries of Europe 6/13/2011 9:09:48 AM
Labtec GmbH Opens Europe’s Most Modern GMP Manufacturing Facility for Transdermal Patches and Oral Films 5/25/2011 9:41:35 AM
APR Applied Pharma Research S.A. and Labtec GmbH Announce Filing for Approval in Europe of Zolmitriptan Oral Dispersible Film (ODF) 12/2/2010 9:33:04 AM
Labtec GmbH's Sufentanil Patch for Chronic Pain Enters Phase II in Cooperation With Hameln Pharmaceuticals gmbh 11/1/2010 10:59:18 AM
APR Applied Pharma Research S.A. and Labtec GmbH Enter Into Exclusive Licensing Agreement With Ferrer Internacional for the Registration and Marketing of Donepezil Oral Dispersible Film in Spain, Portugal and Germany 10/1/2010 8:57:20 AM
APR Applied Pharma Research S.A. and Labtec GmbH Announce the Successful Completion of the Pivotal Clinical Study on Zolmitriptan RapidFilm(R), and Its Upcoming Submission for Registration in Europe 9/15/2010 7:52:52 AM
Labtec GmbH and GlaxoSmithKline (GSK) Finalize License Agreement 6/21/2010 8:06:00 AM
//-->